Jonathan Block
Stock Analyst at Stifel Nicolaus
(3.98)
# 1,774
Out of 5,023 analysts
601
Total ratings
48.1%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Reiterated: Hold | $235 | $218.89 | +7.36% | 13 | Oct 2, 2026 | |
| COO The Cooper Companies | Reiterated: Buy | $70 | $56.91 | +23.00% | 39 | Oct 1, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Buy | $80 → $85 | $69.97 | +21.48% | 43 | Sep 22, 2026 | |
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $22.14 | - | 43 | Sep 18, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $31 | $23.46 | +32.14% | 26 | Sep 18, 2026 | |
| ZTS Zoetis | Reiterated: Hold | n/a | $69.69 | - | 61 | Sep 18, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $20 → $22 | $18.96 | +16.03% | 8 | Sep 15, 2026 | |
| TRUP Trupanion | Reiterated: Hold | $28 → $29 | $23.58 | +22.99% | 45 | Aug 20, 2026 | |
| IDXX IDEXX Laboratories | Reiterated: Buy | $675 | $518.39 | +30.21% | 68 | Aug 14, 2026 | |
| SKIN SkinHealth Systems | Reiterated: Hold | $2 → $1 | $0.63 | +58.73% | 18 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 | $16.50 | +33.33% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $8.67 | +61.48% | 44 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $225 → $180 | $131.69 | +36.68% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $84 → $95 | $84.88 | +11.92% | 34 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $90 → $95 | $85.36 | +11.29% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $143.74 | +46.10% | 104 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8 | $9.88 | -19.03% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $0.6432 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $45 | $163.75 | n/a | 22 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 | $0.0002 | n/a | 1 | Jul 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $41 → $47 | $219.72 | n/a | 3 | May 15, 2017 |
ResMed
Oct 2, 2026
Reiterated: Hold
Price Target: $235
Current: $218.89
Upside: +7.36%
The Cooper Companies
Oct 1, 2026
Reiterated: Buy
Price Target: $70
Current: $56.91
Upside: +23.00%
Inspire Medical Systems
Sep 22, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $69.97
Upside: +21.48%
Elanco Animal Health
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.14
Upside: -
Envista Holdings
Sep 18, 2026
Reiterated: Buy
Price Target: $31
Current: $23.46
Upside: +32.14%
Zoetis
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $69.69
Upside: -
Beta Bionics
Sep 15, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $18.96
Upside: +16.03%
Trupanion
Aug 20, 2026
Reiterated: Hold
Price Target: $28 → $29
Current: $23.58
Upside: +22.99%
IDEXX Laboratories
Aug 14, 2026
Reiterated: Buy
Price Target: $675
Current: $518.39
Upside: +30.21%
SkinHealth Systems
Aug 11, 2026
Reiterated: Hold
Price Target: $2 → $1
Current: $0.63
Upside: +58.73%
Aug 7, 2026
Reiterated: Hold
Price Target: $22
Current: $16.50
Upside: +33.33%
Aug 7, 2026
Reiterated: Hold
Price Target: $14
Current: $8.67
Upside: +61.48%
Aug 6, 2026
Rated: Buy
Price Target: $225 → $180
Current: $131.69
Upside: +36.68%
Aug 5, 2026
Reiterated: Hold
Price Target: $84 → $95
Current: $84.88
Upside: +11.92%
Jul 31, 2026
Rated: Buy
Price Target: $90 → $95
Current: $85.36
Upside: +11.29%
Jul 30, 2026
Reiterated: Buy
Price Target: $210
Current: $143.74
Upside: +46.10%
May 11, 2026
Reiterated: Hold
Price Target: $9 → $8
Current: $9.88
Upside: -19.03%
Jan 7, 2022
Reiterated: Buy
Price Target: $10 → $9
Current: $0.6432
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $55 → $45
Current: $163.75
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $41 → $47
Current: $219.72
Upside: n/a